EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.

Show other versions (1)

Cutaneous Leishmaniasis (CL) is a parasitic infection classified by the WHO as one of the most uncontrolled spreading neglected diseases. Syria is endemic for Leishmania tropica and Leishmania major, causing CL in the Eastern Mediterranean. The large-scale displacement of Syrian refugees exacerbated...

Full description

Saved in:
Bibliographic Details
Main Authors: Rana El Hajj (Author), Hanady Bou Youness (Author), Laurence Lachaud (Author), Patrick Bastien (Author), Carine Masquefa (Author), Pierre-Antoine Bonnet (Author), Hiba El Hajj (Author), Ibrahim Khalifeh (Author)
Format: Book
Published: Public Library of Science (PLoS), 2018-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items